Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Dr Gunson warned DHSS civil servants that there could be "considerable publicity [...] concerning the safety of American Factor VIII"

Published on: 22 July, 2024

The line "no conclusive proof" first appeared in a briefing note to the Prime Minister.

Published on: 22 July, 2024

Dr Galbraith wrote to the DHSS recommending the withdrawal of US blood products due to the risk of AIDS transmission.

Published on: 24 September, 2024

The Council of Europe's Committee of Ministers' resolution recommending "all necessary steps and measures with respect to" AIDS be taken was adopted.

Published on: 22 July, 2024

The publication of the leaflet "AIDS and how it affects blood donors" was announced.

Published on: 22 July, 2024

The Expert Advisory Group on AIDS had its first meeting.

Published on: 22 July, 2024

The second leaflet, titled "AIDS; important new advice for blood donors", was made available to Regional Transfusion Centres.

Published on: 22 July, 2024

It was discovered that heat will inactivate hepatitis virus (in albumin).

Published on: 22 July, 2024

Cutter conducted experiments with heat treatment which showed Factor 9 activity could be preserved.

Published on: 22 July, 2024

Research was underway at PFC to find a way of physically removing Hepatitis B.

Published on: 22 July, 2024

Dr Harvey Alter called for viral inactivation. Calls were made by others too.

Published on: 22 July, 2024

Cutter created a task force to try to solve "the hepatitis problem".

Published on: 22 July, 2024

Behringwerke conducted experiments in heat treatment and began clinical trials.

Published on: 22 July, 2024

Hyland experimented with dry heat approach.

Published on: 22 July, 2024

Behringwerke presented its heat-treated process at the Bonn Conference.

Published on: 22 July, 2024

PFC started performing experiments on pasteurisation.

Published on: 22 July, 2024

Alpha assessed it had the "nucleus of a process that needs about three or four months' work", and applied for a FDA licence for heat-treated product in January 1983.

Published on: 22 July, 2024

BPL started development work on a heat-treated 'Hepatitis-Safe' Factor 8 product.

Published on: 22 July, 2024

FDA licensed Hyland's dry heat-treated product.

Published on: 22 July, 2024

FDA licensed Armour's heat-treated product, followed by Alpha's and Cutter's products in February 1984.

Published on: 22 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 1996
  • Page 1997
  • Page 1998
  • Page 1999
  • Current page 2000
  • Page 2001
  • Page 2002
  • Page 2003
  • Page 2004
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.